Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CUE | AMGN | VRTX | BMY | REGN |
| Company | Cue Biopharma Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 1.9000 | 313.39 | 401.50 | 43.90 | 926.94 |
| High | 2.1900 | 322.60 | 405.67 | 44.33 | 955.20 |
| Low | 1.8700 | 308.82 | 397.59 | 43.69 | 926.94 |
| Last | 2.0900 | 309.84 | 402.18 | 43.85 | 954.23 |
| Change | +0.2100 | +31.45 | +2.02 | +0.15 | +16.62 |
| % Change | +11.17% | +11.30% | +0.50% | +0.34% | +1.77% |
| Volume | 563,027 | 7,782,475 | 599,002 | 7,713,033 | 279,108 |
| 20-Day Average Volume | 355,483 | 2,538,474 | 997,900 | 14,230,701 | 503,960 |
| Previous Close | 1.8800 | 278.39 | 400.16 | 43.70 | 937.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.6782 | 272.28 | 398.45 | 47.46 | 909.57 |
| 20-Day Raw Stochastic | 90.98% | 82.01% | 65.78% | 6.19% | 96.05% |
| 20-Day Relative Strength | 58.52% | 72.16% | 47.49% | 28.39% | 57.67% |
| Weighted Alpha | -71.97 | +33.86 | +14.52 | -36.95 | +25.62 |
| Today's Opinion | 56% Sell | 24% Buy | 8% Buy | 100% Sell | 72% Buy |
| Previous Opinion | 64% Sell | 16% Sell | 8% Buy | 88% Sell | 48% Buy |
| Last Month's Opinion | 100% Sell | 24% Sell | 24% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +54.58% since 04/26/24 | +15.36% since 04/26/24 | +1.01% since 04/26/24 | -2.23% since 04/26/24 | +7.67% since 04/26/24 |
| Low | 1.3700 on 04/30/24 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 43.33 on 05/02/24 | 883.20 on 04/29/24 |
| High | 2.1900 on 05/03/24 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 45.38 on 04/29/24 | 954.10 on 05/03/24 |
| 1-Month | |||||
| %Chg | +19.21% since 04/03/24 | +13.50% since 04/03/24 | -1.79% since 04/03/24 | -15.96% since 04/03/24 | unch since 04/03/24 |
| Low | 1.3027 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 2.1900 on 05/03/24 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 52.08 on 04/04/24 | 962.20 on 04/04/24 |
| 3-Month | |||||
| %Chg | -13.88% since 02/02/24 | -3.63% since 02/02/24 | -5.46% since 02/02/24 | -9.98% since 02/02/24 | +0.61% since 02/02/24 |
| Low | 1.3027 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 2.5800 on 02/12/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -13.88% since 11/03/23 | +15.42% since 11/03/23 | +6.72% since 11/03/23 | -16.98% since 11/03/23 | +16.41% since 11/03/23 |
| Low | 1.3027 on 04/25/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 43.33 on 05/02/24 | 783.57 on 11/10/23 |
| High | 3.2491 on 12/08/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 91,449 | 149,321,728 | 103,424,960 | 88,584,272 | 102,913,952 |
| Shares Outstanding, K | 48,643 | 536,376 | 258,459 | 2,027,100 | 109,762 |
| Annual Sales | 5,490,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 13,117,200,000 |
| Annual Net Income | -50,730,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 3,953,600,000 |
| Last Quarter Sales | 1,820,000 | 8,196,000,000 | 2,517,700,000 | 11,865,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -13,430,000 | 767,000,000 | 968,800,000 | -11,911,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.98 | 0.60 | 0.39 | 0.45 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.28 on 04/08/24 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | -4.40 on 04/25/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 05/06/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.600 on 04/04/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 04/04/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 29.92 | 42.10 | 24.04 |